Alexander Y. Tokman - 02 Mar 2026 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Chief Executive Officer, Director
Signature
/s/ Alexander Y. Tokman by Mark Busch, attorney-in- fact
Issuer symbol
NDRA
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 21:48:18 UTC
Previous filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tokman Alexander Y Chief Executive Officer, Director C/O ENDRA LIFE SCIENCES INC., 3600 GREEN COURT, SUITE 350, ANN ARBOR /s/ Alexander Y. Tokman by Mark Busch, attorney-in- fact 04 Mar 2026 0001334483

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NDRA Common Stock Award +26,921 +36% $0.000000* 101,926 02 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include unvested restricted stock units ("RSUs").
F2 Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026.